Royal Bank Of Canada Dyadic International Inc Transaction History

Royal Bank Of Canada

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.39 - $2.27 $5,383 - $8,791	-3,873 Reduced 91.43%	363 $0
Q1 2024 Nov 05, 2024	BUY	$1.29 - $1.67 $4,996 - $6,467	3,873 Added 1066.94%	4,236 $7,000
Q1 2024 May 15, 2024	SELL	$1.29 - $1.67 $81 - $105	-63 Reduced 1.47%	4,236 $7,000
Q4 2023 Feb 14, 2024	SELL	$1.52 - $2.04 $2,410 - $3,235	-1,586 Reduced 26.95%	4,299 $6,000
Q3 2023 Nov 14, 2023	SELL	$1.71 - $2.08 $186 - $226	-109 Reduced 1.82%	5,885 $11,000
Q2 2023 Aug 14, 2023	BUY	$1.56 - $2.38 $5,382 - $8,211	3,450 Added 135.61%	5,994 $11,000
Q4 2022 Feb 14, 2023	SELL	$1.18 - $2.32 $5,239 - $10,300	-4,440 Reduced 63.57%	2,544 $3,000
Q3 2022 Nov 14, 2022	BUY	$1.65 - $3.42 $7,326 - $15,184	4,440 Added 174.53%	6,984 $13,000
Q3 2021 Nov 15, 2021	SELL	$3.3 - $6.49 $14,602 - $28,718	-4,425 Reduced 63.5%	2,544 $14,000
Q2 2021 Aug 16, 2021	BUY	$3.35 - $5.67 $23,346 - $39,514	6,969 New	6,969 $25,000

4.77M

20.6K

Ticker DYAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,423,100
Market Cap $51.7M
Description
Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vac...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.